J. Nørdling

Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist. A meta-analysis of two randomized, placebo-controlled, multicentre studies in patients with benign prostatic obstruction (symptomatic BPH). European Tamsulosin Study Group.

Christopher R. Chapple, J J Wyndaele, J. Nørdling et al. · PubMed · 1996 · 219 citations

Safety and efficacy of alfuzosin 10 mg once‐daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double‐blind, placebo‐controlled studies

Claus G. Roehrborn, P. Van Kerrebroeck, J. Nørdling · British Journal of Urology · 2003 · 182 citations

Primary Evaluation of Patients Suspected of Having Interstitial Cystitis (IC)

J. Nørdling, Faqar H. Anjum, J. J. Bade et al. · European Urology · 2003 · 182 citations

Urology, Gastroenterology, Diagnosis +5

Voiding Patterns and Prevalence of Incontinence in Women.: A Questionnaire Survey

Peter Sommer, T. Bauer, Kurt K. Nielsen et al. · British Journal of Urology · 1990 · 175 citations

Validation of the self‐administered Danish Prostatic Symptom Score (DAN‐PSS‐1) system for use in benign prostatic hyperplasia

B.J. HANSEN, Henrik Flyger, Klaus Brasso et al. · British Journal of Urology · 1995 · 147 citations